FCHKX | FHKAX | FCHKX / FHKAX | |
Total Expense Ratio | 1.93 | 1.18 | 164% |
Annual Report Gross Expense Ratio | 1.93 | 1.18 | 164% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 10.710 | 11.105 | 96% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.15B | 1.15B | 100% |
Annual Yield % from dividends | 0.60 | 1.16 | 52% |
Returns for 1 year | 16.32 | 17.23 | 95% |
Returns for 3 years | 24.92 | 27.70 | 90% |
Returns for 5 years | 1.42 | 5.70 | 25% |
Returns for 10 years | 13.70 | 20.09 | 68% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETHSX | 12.98 | -0.13 | -0.99% |
Eaton Vance Worldwide Health Sci A | |||
RGLEX | 25.58 | -0.32 | -1.24% |
American Funds Global Insight R-4 | |||
IGISX | 18.99 | -0.24 | -1.25% |
Voya Growth and Income Port S2 | |||
HSLYX | 44.63 | -0.74 | -1.63% |
Hartford Small Cap Growth Y | |||
SEKCX | 17.44 | -0.35 | -1.97% |
DWS Emerging Markets Equity C |